logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Mobile Logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Image Alt
News & Media

Phoenix

Oct 12
Phoenix
News

PHOENIX @ BNN Quarterly (Oct 2022)

PHOENIX was featured in the latest BNN QUARTERLY issue (Oct 2022), with a special highlight on our PHOENIX-OITB Open Call:  “Join Forces to Overcome Common Barriers in Nanopharmaceutical Development” (pages 34-36) and an article about PHOENIX at the MTC MEDTECH circle event in September (page 62).

Enjoy reading!

READ now
Like

Related Posts

Sep 12
Phoenix

Updated Service Portfolio Now Available!

Read More
Aug 5
Phoenix

Testimonial from NaDeNo Nanoscience AS, recipient of the Open Call

Read More
Aug 4
Phoenix

Expert Interviews: Advanced Analytical Characterization

Read More

Post Categories

  • Events
  • News
  • Newsletter
  • Project Outcomes

Recent News

  • Updated Service Portfolio Now Available! September 12, 2025
  • Polymer-based imaging agent: Interview with Prof. Mangala Srinivas September 5, 2025
  • Advanced Nanoparticle Characterization Technologies from RECENDT August 25, 2025

Tags

AdMa ANTHOS24 call characterization CMC computer simulation customers European Researchers’ Night 2023 Fabry Fabry Disease GLA interview in vitro manufacturing MRI nanomedicine nanoparticles nanopharmaceuticals nanotechnology OITB pharmaceuticals physchem podcast quality-by-design quality control rare diseases Regulatory advice Regulatory Support services SSbD sustainability Training video webinar

Contact us

MyBiotech GmbH
Industriestraße 1B
66802 Überherrn
Germany
info@phoenix-oitb.eu

Join the PHOENIX community!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953110.

 

Downloads  |  Legal Notice  |  Privacy Policy